Enhanced dehydroepiandrosterone levels are positively correlated with N3 sleep stage in long-term mindfulness meditation practitioners
Ravindra P. Nagendra, Talakad N. Sathyaprabha, Bindu M Kutty
Sleep Science June 17, 2022 DOI: 000710.5935/1984-0063.20220039 (opens in new tab) via DOAJ
Summary
AI-generated from the abstractLong-term Vipassana meditators show increased N3 (slow-wave) and REM sleep stages compared to non-meditators. Evening cortisol levels were similar between groups, but early morning cortisol, diurnal dehydroepiandrosterone (DHEA), and melatonin were significantly higher in meditators. Diurnal DHEA correlated significantly with N3 sleep stage in meditators. These findings suggest that long-term Vipassana meditation practice modulates the hypothalamic-pituitary-adrenal (HPA) axis and thereby influences sleep, providing evidence to explore mechanisms involved with mindfulness meditation intervention in insomnia.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 65 |
| Population | Long-term Vipassana meditators and controls, males, 30-60 years of age |
| Intervention | Vipassana meditation |
| Duration | Two-day consecutive whole night polysomnography recording |
| Topics | Meditation |
| Keywords | Dehydroepiandrosterone Hydrocortisone Melatonin Sleep, slow-wave |
| Key finding | Long-term Vipassana meditators have higher diurnal DHEA, early morning cortisol, and melatonin, along with increased N3 and REM sleep, and diurnal DHEA correlates with N3 sleep. |
Abstract
Objectives: Meditation practices positively influence the neural, hormonal and autonomic systems. We have demonstrated that long-term practice of mindfulness meditation increases N3 and rapid eye movement (REM) sleep stages and bring efficient autonomic modulation during sleep. In the present study, the probable humoral correlation that could bring about these changes is evaluated. Material and Methods: Long-term Vipassana meditators (n=41) and controls (n=24) (males, 30-60 years of age) underwent a two-day consecutive whole night polysomnography recording. During the second day, with exposure to 100Lux brightness, blood was sampled from the antecubital vein between 8-9 PM and in subsequent early morning. Sleep stage was scored as per American Society of Sleep Medicine (ASSM) guidelines for the second-day recording. Sleep-related hormones were estimated - melatonin by radioimmunoassay; dehydroepiandrosterone (DHEA), cortisol, growth hormone (GH) and prolactin with enzyme-linked immunosorbent assay (ELISA); DHEA/cortisol ratio was calculated. Percentage of sleep stages and hormonal levels were compared between both groups using independent ‘t’ test and Pearson’s correlation was estimated between sleep stages and hormonal levels. Results: Meditators showed increased N3, REM sleep stages. Though evening cortisol was comparable between the two groups; early morning cortisol, diurnal DHEA and melatonin were significantly higher in meditators. Diurnal DHEA correlated significantly with the N3 sleep stage in meditators. Discussion: Higher diurnal DHEA despite variations in corresponding cortisol in meditators demonstrates that long-term Vipassana meditation practice modulates the hypothalamicpituitary-adrenal (HPA) axis and thereby influences sleep. Thus, the study provides evidence to explore the mechanism most likely involved with mindfulness meditation intervention in insomnia.